Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N FIESSINGER

Showing results (221-230 of 315) with videos related to

Pageof 32
Sort By:
Presse Medicale (Paris, France : 1983)|April 28, 1984
[Intra-arterial urokinase-lys-plasminogen thrombolytic treatment. An alternative]C Debure, M Roncatot, J M Pernes, et al.
Presse Medicale (Paris, France : 1983)|July 14, 1984
[Multiple arterial lesions in von Recklinghausen's disease. A case]C Debure, J N Fiessinger, P Bruneval, et al.
Annales De Medecine Interne|January 1, 1986
[Phlebitis of the arm. Apropos of 45 cases]J J Monsuez, P Larroque, J N Fiessinger, et al.
Presse Medicale (Paris, France : 1983)|January 22, 1998
[Arterial lesions of the upper limbs in Horton disease. Surgical revascularization by bilateral carotid-humeral bypass]P Soury, D Brisset, C Saliou, et al.
Revue De Pneumologie Clinique|January 1, 1987
[Functional follow-up of pulmonary localization of scleroderma]E Orvoen-Frija, M F Dore, L Villoingt, et al.
Journal De Radiologie|August 1, 2000
[Pulmonary embolism: is scintigraphy useful after initial angio-CT?]J F Paul, J N Fiessinger, A Hernigou, et al.
Journal of Cellular and Molecular Medicine|October 13, 2009
Platelet microparticle levels: a biomarker of thromboangiitis obliterans (Buerger's disease) exacerbationL Darnige, D Helley, A M Fischer, et al.
JAMA|February 26, 1988
Long-term treatment of acute deep venous thrombosis with low-molecular-weight heparin derivativeJ F Vitoux, J N Fiessinger, M Roncato, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|October 1, 1978
Salivary immunoglobulins in progressive systemic sclerosisJ N Fiessinger, J P Camilleri, C Amat, et al.
Thrombosis and Haemostasis|June 3, 1998
Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI groupB A Charbonnier, J N Fiessinger, J D Banga, et al.
Pageof 32

Showing results (221-230 of 315) with videos related to

Sort By:
Pageof 32
Presse Medicale (Paris, France : 1983)|April 28, 1984
[Intra-arterial urokinase-lys-plasminogen thrombolytic treatment. An alternative]C Debure, M Roncatot, J M Pernes, et al.
Presse Medicale (Paris, France : 1983)|July 14, 1984
[Multiple arterial lesions in von Recklinghausen's disease. A case]C Debure, J N Fiessinger, P Bruneval, et al.
Annales De Medecine Interne|January 1, 1986
[Phlebitis of the arm. Apropos of 45 cases]J J Monsuez, P Larroque, J N Fiessinger, et al.
Presse Medicale (Paris, France : 1983)|January 22, 1998
[Arterial lesions of the upper limbs in Horton disease. Surgical revascularization by bilateral carotid-humeral bypass]P Soury, D Brisset, C Saliou, et al.
Revue De Pneumologie Clinique|January 1, 1987
[Functional follow-up of pulmonary localization of scleroderma]E Orvoen-Frija, M F Dore, L Villoingt, et al.
Journal De Radiologie|August 1, 2000
[Pulmonary embolism: is scintigraphy useful after initial angio-CT?]J F Paul, J N Fiessinger, A Hernigou, et al.
Journal of Cellular and Molecular Medicine|October 13, 2009
Platelet microparticle levels: a biomarker of thromboangiitis obliterans (Buerger's disease) exacerbationL Darnige, D Helley, A M Fischer, et al.
JAMA|February 26, 1988
Long-term treatment of acute deep venous thrombosis with low-molecular-weight heparin derivativeJ F Vitoux, J N Fiessinger, M Roncato, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|October 1, 1978
Salivary immunoglobulins in progressive systemic sclerosisJ N Fiessinger, J P Camilleri, C Amat, et al.
Thrombosis and Haemostasis|June 3, 1998
Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI groupB A Charbonnier, J N Fiessinger, J D Banga, et al.
Pageof 32